Delivery Order SPE2DB22D1041-SPE2DB24FUAS2
- Not listed
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $19,520.62 contract is for the delivery of the HIV antiretroviral medication BIKTARVY 50-200-25 MG TABLET in 30-count bottles. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up...
- This federal contract award is a delivery order issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical sourcing and distribution company. The $14,321.64 fixed-price contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a brand name antiretroviral medication. The contract has a performance period through March 13, 2024 and is not associated with...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm-fixed-price delivery order contract valued at $57,828.91 for the supply of 4,564,247,547 units of the HIV treatment medication BIKTARVY. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,035.68 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used to treat HIV infection. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is a delivery order valued at $1,496.44 for the supply of the antiretroviral medication BIKTARVY. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with a performance period through March 11, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $80,169.87 firm fixed price delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a brand name antiretroviral medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary contract vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $9,392.12 firm fixed price delivery order is for the supply of Biktarvy, a brand name antiretroviral medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,815.46 firm-fixed-price delivery order contract is for the supply of the HIV medication Biktarvy, with a period of performance through May 14, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,470.72 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used in the treatment of HIV/AIDS. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $57,385.59 firm fixed-price delivery order is for the supply of the HIV medication Biktarvy, with an ultimate completion date of January 18, 2024. This contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB24FUAS2Delivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $19,671.99 firm fixed price contract is for the delivery of the HIV medication BIKTARVY 50-200-25 MG TABLET in 30-count packages. This award is a part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a wide range of pharmaceutical products and medical supplies in support of military treatment programs and facilities. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this delivery order and sole awardee of the broader IDC, which is the primary vehicle for the company to deliver medications and healthcare materials to the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 4/4/24 |